An urgent need for experimental animal model of autism in drug development

Annals of Neurosciences

Volumn 22, Issue 1, 2015, Pages 44-49

  Ruhela, Rakesh K ^a   Prakash, Ajay ^a   Medhi, Bikash ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Animal model; Autism; Construct validity; Drug therapy; Face validity

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; BETA ENDORPHIN; MORPHINE; NALTREXONE; NEUROTRANSMITTER;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; COMORBIDITY; DISEASE ASSOCIATION; DRUG RESEARCH; EPILEPSY; EXPERIMENTAL MODEL; FRAGILE X SYNDROME; HUMAN; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; RETT SYNDROME; SOCIAL INTERACTION; TRANSLATIONAL RESEARCH; TUBEROUS SCLEROSIS;

EID: 84929484987     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.220210     Document Type: Article

References (57)

1. Georgiades S, Szatmari P, Zwaigenbaum L, et al. Structure of the autism symptom phenotype: a proposed multidimensional model. Am Acad Child Adolesc Psychiatry. 2007; 46: 188-96.
2. Crawley JN. Translational animal models of autism and neurodevelopmental disorders. Dialogues in Clinical Neuroscience. 2012; 14(3): 293-305.
3. Lacroix A, Guidetti M, Roge B et al. Recognition of emotional and nonemotional facial expressions: A comparison between Williams syndrome and autism. Research in Developmental Disabilities. 2009; 30: 976-985.
4. Niklasson L, Rasmussen P, Óskarsdóttir S et al. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Research in Developmental Disabilities. 2009; 30: 763-773.
5. Kuban KCK, O'Shea TM, Allred EN, et al. Positive screening on the Modified Checklist for Autism in Toddlers (M-CHAT) in extremely low gestational age newborns. The Journal of Pediatrics. 2009; 154: 535-540.
6. Matson JL, Wilkins J, Sevin JA, et al. Reliability and item content of the Baby and Infant Screen for Children with autism Traits (BISCUIT): Parts 1-3. Research in Autism Spectrum Disorders. 2009; 3: 336-344.
7. Feng T, Ann MM, Robert HL. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. Annals of the New York Academy of Sciences. 2010; 1199: 186-193.
8. Sabine MK, Poustka A. Animal models of autism. Drug Discovery Today: Disease Models. 2006; 3(4): 313-318.
9. Tropepe V, Sive HL. Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes Brain Behav. 2003; 2: 268-281.
10. McBride SM, Choi CH, Wang Y, et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron. 2005; 45: 753-764.
11. McKinney WT, Bunney WE Jr. Animal model of depression. Review of evidence: implications for research. Arch. Gen. Psychiatry. 1969; 21: 240-248.
12. Nakatani J, Tamada K, Hatanaka F, et al. Abnormal behavior in a chromosomeengineered mouse model for human 15q11-13 duplication seen in autism. Cell. 2009; 137: 1235-1246.
13. Rinaldi T, Perrodin C, Markram H. Hyper-Connectivity and Hyper-Plasticity in the Medial Prefrontal Cortex in the Valproic Acid Animal Model of Autism. Front Neural Circuits. 2008; 2: 4.
14. Stephane J, Konstantin R, Kurt H, et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. PNAS. 2008; 105(5): 1710-1715.
15. Wagner GC, Reuhl KR, Cheh M, et al. A New Neurobehavioral Model of Autism in Mice: Pre- and Postnatal Exposure to Sodium Valproate J Autism Dev Disord. 2006; 36: 779-793.
16. Dendrinos G, Hemelt M, Keller A. Prenatal VPA exposure and changes in sensory processing by the superior colliculus. Front Integr Neurosci. 2011 Oct 20; 5: 68.
17. Makiko K, Tetsuo O, Seiji S et al. Observation of fetal brain in a rat valproate-induced autism model:a developmental neurotoxicity study. J. Devl Neuroscience. 2009; 27: 399-405.
18. Fatemi SH, Pearce DA, Brooks AI et al. Prenatal Viral Infection in Mouse Causes Differential Expression of Genes in Brains of Mouse Progeny: A Potential Animal Model for Schizophrenia and Autism. Synapse. 2005; 57: 91-99.
19. Gubbay SS, Lobascher M, Kingerlee P. A neurologic appraisal of autistic children: results of a western Australian survey. Dev Med Child Neurol. 1970; 12: 422-9.
20. Tuchman RF, Rapin I and Shinnar S. Autistic and dysphasic children: II. Epilepsy. Pediatrics. 1991; 88: 1219-1225.
21. Olsson I, Steffenburg S, Gillberg C. Epilepsy in autism and autistic like conditions. Arch Neurol. 1998; 45: 666-668.
22. Kanner L. Autistic disturbances of affective contact. Acta Paedopsychiatr. 1968; 35 (4): 100-36.
23. Tuchman R, Rapin I. Epilepsy in autism. Lancet Neurol. 2002; 1: 352-358.
24. Pavone P, Incorpora G, Fiumara A, et al. Epilepsy is not a prominent feature of primary autism. Neuropediatrics. 2004; 35: 207-210.
25. Gabis L, Pomeroy J, Andriola MR. Autism and epilepsy: cause, consequence, comorbidity, or coincidence? Epilepsy Behav. 2005; 7: 652-656.
26. Danielsson S, Gillberg IC, Billstedt E, et al. Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia. 2005; 46: 918-923.
27. Hara H. Autism and epilepsy: a retrospective follow-up study. Brain & development. 2007; 29: 486-490.
28. Tuchman R, Solomon LM. Convulsing toward the pathophysiology of autism. Brain Developmental. 2009; 31: 95-103.
29. Bauman ML, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology. 1985; 35: 866-874.
30. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci. 2005; 23(2-3): 183-7.
31. Raymond G, Bauman ML, Kemper TL. Hippocampus in autism: A Golgi study. Acta Neuropathology. 1996; 91: 117-119.
32. Joao CMM, Paula JM, Roberta MC, et al. Temporal lobe epilepsy and social behavior: An animal model for autism? Epilepsy & Behavior. 2008; 13: 43-46.
33. El Achkar CM, Spence SJ. Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Eplilepsy Behav, 2015; S1525 5050(14): 00689-1.
34. Pierce K, Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry. 2001; 49: 655-664.
35. Caston J, Yon E, Mellier D, et al. An animal model of autism: behavioural studies in the GS guinea pig. Eur J Neurosci. 1998; 10: 2677-2684.
36. Lalonde R, Manseau M and Boetz MI. Exploration and habituation in Purkinje cell degeneration mutant mice. Brain Research. 1989; 479: 201-203.
37. Kamiguchi H, Hlavin ML, Lemmon V. Role of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci. 1998; 12: 48-55.
38. Leaton RN, Supple WF Jr. Medial cerebellum and long-term habituation of acoustic startle in rats. Behav Neurosci. 1991; 105: 804-816.
39. Kumar B, Prakash A, Kumar R, et al. Drug therapy in autism: a present and future perspective. Pharmacological Reports. 2012; 64: 1291-1304.
40. Benton, D., and P.F. Brain 1988 The role of opioid mechanisms in social interaction and attachment. Pp. 217-235 in R.J. Rodgers and S.J. Cooper, eds., Endorphins, Opiates and Behavioural Processes. Chichester, England: John Wiley & Sons.
41. Panksepp J, Herman B, Connor R et al. The biology of social attachments: opiates alleviate separation distress. Biol Psychiatry. 1978; 13: 607-618.
42. Panksepp J. A neurochemical theory of autism. Trends Neurosci. 1979; 2: 174-177.
43. Deutsch SI. Rationale for the administration of opiate antagonists in treating infantile autism. Am J Ment Defic. 1986; 90(6): 631-5.
44. David JG, Tatyana DS, Raul RG, et al. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor- deficient mice. PNAS 2001; 98 (26): 15312-15317.
45. David JD, Samuel G. The role of dopamine in mood disorders. Comprehensive Psychiatry 1992; 33 (2): 115-120.
46. Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 2004; 65 Suppl (14): 11-7.
47. Franklin RS, Anissa AD, Diana M, et al. Dopamine Transporters, D2 Receptors, and Dopamine Release in Generalized Social Anxiety Disorder. Depress Anxiety. 2009; 26(5): 411-418.
48. Chanda S, Samuele M, Marius W et al. Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin- 3 mutation. PNAS 2013; 110(41): 16622-16627.
49. Hsiao EY, Sara W. McBride, Janet Chow et al. Modeling an autism risk factor in mice leads to permanent immune dysregulation. PNAS. 2012; 109(31): 12776- 12781.
50. Jacob J, Vanessa RSM, Sean CC et al. Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome. Disease Models & Mechanisms. 2014; 7: 107-117.
51. Jiang YH, Michael D. Ehlers. Modeling Autism by SHANK Gene Mutations in Mice. Neuron. 2013; 78(1): 8-27.
52. Magali HA, Charlotte JT, Andreas MG, et al. Garner. Autism-Associated Mutations in ProSAP2/Shank3 Impair Synaptic Transmission and Neurexin-Neuroligin Mediated Transsynaptic Signaling. J. Neurosci. 2012; 32(43): 14966-14978.
53. Narita M, Oyabu A, Imura Y, et al. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acidinduced autism model rat. Neuroscience Research. 2010; 66: 2-6.
54. Reynolds S, Alexandre M, Darragh PD. Sensory and Motor Characterization in the Postnatal Valproate Rat Model of Autism. Dev Neurosci. 2012; 34: 258-267.
55. Xinga B, Zhaoa Y, Zhangc H, et al. Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant- like effect in the rat forced swim test. Brain Research Bulletin. 2011; 85: 153-157.
56. Gigliucci V, Leonzino M, Busnelli M et al. (2014) Region specific up-regulation of oxytocin receptors in the opioid Oprm1−/− mouse model of autism. Frontiers in Pediatrics 2014; 2: (91).
57. Laugeray A, Herzine A, Perche O, et al. Preand postnatal exposure to low dose glufosinate ammonium induces autismlike phenotypes in mice. Front Behav Neurosci 2014; 8: 390.